Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 7,500.00
-360.00 (-4.58%)
At close: Feb 6, 2026
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 542.56 billion as of February 6, 2026. Its market cap has increased by 104.48% in one year.
Market Cap
542.56B
Enterprise Value
558.03B
Revenue
56.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,500.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 542.56B, an increase of 475.60%. That is a compound annual growth rate of 7.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 542.56B | 7.03% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.21T |
| Celltrion | 48.03T |
| ALTEOGEN | 20.14T |
| Sam Chun Dang Pharm. | 11.55T |
| Huons Global | 612.59B |
| BioNote | 573.70B |
| Genomictree | 566.62B |
| FutureChem Co.,Ltd | 531.41B |